Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching

Lucy Kerr • Flavio A. Cadegiani • Fernando Baldi • et. al.,, DOI: 10.7759/cureus.21272  This article has been corrected. See Kerr L, Cadegiani F A, Baldi F, et al. (March 24, 2022) Correction: Ivermectin Prophylaxis Used for COVID-19:…[...]

Read More

Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease

Laurent Chouchana 1,∗, Laure-Hélène Preta 1, Mylène Tisseyre 1, et. al., PMCID: PMC7907730  PMID: 33647327 Remdesivir is a novel adenosine-like nucleotide analogue, representing the first drug approved for coronavirus disease 2019 (COVID-19), albeit an uncertain clinical relevance. In…[...]

Read More